Acurx Pharmaceuticals LLC (ACXP NASDAQ) stock market data APIs
$4.3376
-0.12(-2.8%)
as of September 12, 2025
Try our APIs with
free plan!
Acurx Pharmaceuticals LLC Financial Data Overview
Price chart is built with
Anychart
Acurx Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, develops antibiotics to treat bacterial infections in the United States. The company's lead antibiotic candidate is ibezapolstat, a novel mechanism of action that targets the polymerase IIIC enzyme that is in Phase 2b clinical trial to treat patients with clostridium difficile infections. It also develops ACX-375C, a potential oral and parenteral treatment targeting gram-positive bacteria, including methicillin-resistant staphylococcus aureus, vancomycin-resistant enterococcus, and penicillin-resistant streptococcus pneumonia; and CCP, multiple product candidates for gram-positive infections. Acurx Pharmaceuticals, Inc. was incorporated in 2017 and is headquartered in Staten Island, New York.
Prev. Close
4.3376
Open
4.2188
High
4.3288
Low
4.2188
52 wk Range
3.8-44
Market Cap
6 830 K
Shares Outstanding
1 585 K
EPS
-1.89
Beta
-1.287
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
ETFs with Acurx Pharmaceuticals LLC (top by weight)
Ticker
100-day Price Change
Weight
* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Acurx Pharmaceuticals LLC data using free add-ons & libraries
Get Acurx Pharmaceuticals LLC Fundamental Data
Acurx Pharmaceuticals LLC Fundamental data includes:
- Net Revenue:
- EBITDA:
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-08-12
- EPS/Forecast: -0.18
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Acurx Pharmaceuticals LLC News
New
RSI Alert: Soleno Therapeutics (SLNO) Now Oversold
Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a te...
Acurx Pharmaceuticals regains compliance with Nasdaq’s listing rules
* Acurx Pharmaceuticals (NASDAQ:ACXP [https://seekingalpha.com/symbol/ACXP]) has regained compliance [https://seekingalpha.com/pr/20218879-acurx-pharmaceuticals-inc-regains-full-compliance-with-nas...
Acurx Approves 1-for-20 Reverse Stock Split To Regain Nasdaq Compliance
(RTTNews) - Acurx Pharmaceuticals (ACXP) announced a 1-for-20 reverse stock split of its common shares, set to take effect on August 4, 2025. Trading will begin on a split-adjusted basis on August 5 ...
Acurx Pharmaceuticals, Inc. Announces Reverse Stock Split
Acurx's common stock is expected to begin trading on a post-split adjusted basis on August 5, 2025 STATEN ISLAND, N.Y., July 31, 2025 /PRNewswire/ -- Acurx Pharmaceuticals, Inc. (NASDAQ: ACXP) ("Acur...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
